PHARMACODYNAMICS TERMS Flashcards

(56 cards)

1
Q

study of the time course of drug absorption, distribution, metabolism and elimination

A

pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

application of PK principles to the safe and effective therapeutic management of drugs in a patient

A

clinical pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

the events that occur in the body that lead to a drugs effect

A

mechanism of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

synthesized outside of the body

A

xenobiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

synthesized within the body

A

hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

produces harmful effects

A

poisons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

poisons of biologic origin

A

toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

molecules that binds to another molecule

i.e. drug, hormone, NT

A

ligands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

components of a cell or organism that interact with a drug and initiates the chain of events leading to the drugs observed effects

A

receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

agonist or antagonist act as activators

A

agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

agonist or antagonist act as inhibitors

A

antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

affects multiple receptors on different cells/tissues

A

nonselective drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

exerts more specific binding

A

selective drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

components of a cell or organism that interacts with a drug and initials chain of events leading tot he drugs observed effects

A

receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

aspirin and sarin have what type of drug-receptor bond

A

covalent bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

this drug receptor bond consists of ionic, hydrogen, van Der Waals

nicotine as an example

A

electrostatic bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

lipids have what type of drug receptor bond

A

hydrophobic bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

bind to the same receptor sites as the endogenous agonist

A

primary agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

blind to different regions of the receptor

A

allosteric agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ligand binds only to the active form of the receptor to produce full max effect

A

full agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ligand binds to both active and inactive forms of the receptor but with more affinity for the active form leading to partial effect

A

partial agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

blocks the agonist from binding to the receptor

A

antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

produce a lower response that do full agonist (ceding effect) inhibits the response produced by full agonist

buprenorphine

A

partial agonists

24
Q

refers to the relative ability of a drug receptor complex to produce a maximum response

A

intrinsic efficacy

25
drugs that produce the opposite effect/response of the agonist a receptor is either active or inactive, what is this activity called?
inverse agonist constitutive activity
26
antagonist competes for the same binding spot as the ligand/drug
competitive antagonism
27
nonselective beta blocker competes with norepinephrine and epic reduces resting heart rate exhibits competitive antagonism
propanolol
28
one that does not bind drug when the drug concentration is sufficient to produce maximal effect
spare receptor
29
bind to receptor in an irreversible manner a noncompetitive antagonist reduces the maximal response that an agonist can produce increasing the agonist concentration cannot surmount the inhibitory effect
noncompetitive antagonist
30
drug used to treat hypertension in patients pheochromocytoma
phenoxybenzamine
31
drugs have both agonistic and antagonistic properties
mixed agonist
32
a drug may antagonize the actions of a second drug by binding to and inactivating the second drug heparin reversal with protamine
chemical antagonism
33
many physiologic functions are controlled by opposing regulatory pathways glucocorticoids and insulin
physiologic antagonism
34
mediate actions of endogenous chemical signals NTs, hormones
regulatory proteins
35
protein receptors are activated or inactivated by drugs which themselves can be enzymes
enzymes
36
receptors that regular movement of materials NTs
transport proteins
37
structural elements like tubulin
structural proteins
38
name this effect of receptor regulation: EGF receptor kinase ligand binding leads to internalization of receptor de novo synthesis of receptors rate < receptor degradation decreased total number of cell surface receptors
downregulation
39
name this receptor regulation cells responsiveness to ligand decreases
desensitization
40
name this receptor regulation when responsiveness to a drug diminishes rapidly after administration of a drug i.e. acute tolerance
tachyphylaxis
41
name this receptor regulation an increase in the number of receptors on the surface of target cells
upregulation
42
this the concentration that produces 50% of the maximal response
EC50
43
the maximal response that can be produced by the drug | -maximal effect of a drug can be seen by the plateau of the dose response curve
Emax
44
dose at which 50% of the subject exhibits the quantal effect i.e. therapeutic effect
ED50
45
dose at which 50% of subjects experienced a toxic event
TD50
46
dose at which 50% of subjects died
LD50
47
denotes the amount of drug needed to produce a specified effect EC50 ED50
potency
48
the ratio of equivalent-effective doses used in to compare one drug with another
relative potency
49
do not equate greater potency of a drug with therapeutic superiority one can possibly increase the dose of a less potent and get the same clinical response
equipotent dose
50
a dose response that is defined as either absent or present all or none useful for finding the dose required to produce a specified response in each member of the population
quantal dose response
51
plotting the increment in the percent of the population that responds with a specified effect as the dose is increased
quantal dose response curve
52
range between the minimum toxic dose and the minimum therapeutic dose
therapeutic range
53
TD50/ED50 what is this index? increased means?
therapeutic index greater the margin of safety
54
drugs that have both agonistic and antagonistic properties?
mixed agonist
55
doesn't take any opioids?
opioid naive
56
has been taking a full agonist like oxycodone for pain
opioid tolerant